期刊文献+

坏疽性脓皮病合并骨髓纤维化的研究进展

Progress in Research on Pyoderma Gangrenosum with Primary Myelofibrosis
下载PDF
导出
摘要 坏疽性脓皮病(pyodermagangrenosum,PG)是一种罕见的非感染性破坏性、坏死性单发或多发皮肤溃疡,50%~70%的PG患者合并系统性疾病,因而增加了PG诊断及治疗的难度。PG患者中约半数伴发溃疡性结肠炎,关节炎、自身免疫性疾病以及血液系统疾病(如骨髓瘤、白血病、骨髓增生异常综合症等。
作者 袁玲 邹善华
出处 《中国临床医学》 2014年第3期380-386,共7页 Chinese Journal of Clinical Medicine
  • 相关文献

参考文献60

  • 1Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum , a review[J]. J Cutan Patho!,2003 ,30(2) :97-107.
  • 2Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms[J]. Leukemia,2008 ,22: 14-22.
  • 3Hoffman R,Rondelli D. Biology and treatment of primary myelofibrosisl]], Hematology Am Soc Hematol Educ Program, 2007,346-354.
  • 4Brocq L. Nouvelle contribution a I' etude du phagedenisme geometrique[J]. Ann Dermatol Syphil,1916,6(1) :1-39.
  • 5Brunsting LA, Goeckerman W H , O'Leary P A. Pyoderma gangenosurn , clinical and experimental observations in five cases occurring in adults[J]. Arch Derrnatol , 1930 ,22: 655.
  • 6Powell FC, Schroeter AL, Su WP, et al. Pyoderma gang renosum i a review of 86 patients[J]. Q J Med,1985,55(217): 173-186.
  • 7Powell FC,Su WP,Perry HO. Pyoderma gangrenosurn , classi fica tion and managemen t[J]. J Am Acad Derma tol , 1996, 34 (3) :395-409.
  • 8Powell FC,Schroeter AL,Su wr ,? al. Pyoderma gangrenesum and sarcoidosis[J]. Arch Derrnatol , 1984, 120 (7): 959- 960.
  • 9Korber A, Klode J, AI- Benna S, et al. Etiology of chronic leg ulcers in 31, 619 patients in Germany analyzed by an expert survey[J]. J Dtsch Dermatol Ges,2011 ,9(2): 116-121.
  • 10Tabarroki A, Tiu RV. Immunomodulatory agents in myelofibrosiseJ]. Expert Opin Investig Drugs, 2012, 21 (8): 1141- 1154.

二级参考文献41

  • 1Hoffman R, Ravandi-Kashandi F. Idiopathic myelofibrosis//Philadelphia PA. Hematology: basic principles and practices. Houston: Elsevier Scientific, 2005 : 1255-1257.
  • 2Barosi G, Hoffman R. Idiopathic myelofibrosis. Semin Hematol, 2003,42 : 248-258.
  • 3张之南,杨天楹,郝玉书.血液病学.1版.北京:人民卫生出版社,2003:1459-1469.
  • 4Dong M, Blobe GC. Role of transforming growth factor-beta in hematologic malignancies. Blood, 2006, 107:4589-4596.
  • 5Ciurea SO, Merchant D, Mahmud N, et al. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood, 2007,110:986-993.
  • 6Chagraoui H, Komura E, Tulliez M, et al. Prominent role of TGF- beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood, 2002,100:3495-3503.
  • 7Giraudier S, Chagraoui H, Komura E, et al. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood, 2002, 100: 2932-2940.
  • 8Rameshwar P, Narayanan R, Qian J, et al. NF-κB as a central mediator in the induction of TGF-β in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the reahn of homeostasis. J Immunol, 2000, 165:2271-2277.
  • 9Emadi S, Clay D, Desterke C, et al. IL-8 and its CXCR1 and CXCR2 receptors participate in the control of megakaryocytic proliferation, differentiation, and ploidy in myeloid metaplasia with myelofibrosis. Blood, 2005, 105:464473.
  • 10Rameshwar P, Joshi DD, Yadav P, et al. Mimicry between nenrokinin-1 and fibronectin may explain the transport and stability of increased substance P immunoreactivity in patients with bone marrow fibrosis. Blood, 2001, 97 : 3025-3031.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部